UBS Group’s Revelation Biosciences REVB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $563 | Buy |
250
+134
| +116% | +$302 | ﹤0.01% | 8465 |
|
|
2025
Q1 | $918 | Buy |
+116
| New | +$918 | ﹤0.01% | 8301 |
|
|
2024
Q4 | – | Sell |
-853
| Closed | -$34.9K | – | 8979 |
|
|
2024
Q3 | $34.9K | Buy |
853
+284
| +50% | +$11.6K | ﹤0.01% | 5847 |
|
|
2024
Q2 | $52.2K | Buy |
569
+482
| +554% | +$44.2K | ﹤0.01% | 5513 |
|
|
2024
Q1 | $11.5K | Buy |
+87
| New | +$11.5K | ﹤0.01% | 6009 |
|
|
2023
Q4 | – | Hold |
0
| – | -$63 | – | 7744 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 7828 |
|
|
2023
Q2 | – | Sell |
-1
| Closed | -$1.77K | – | 8304 |
|
|
2023
Q1 | $1.77K | Buy |
+1
| New | +$1.77K | ﹤0.01% | 7552 |
|
|
2022
Q3 | – | Hold |
0
| – | -$6K | – | 9608 |
|
|
2022
Q2 | – | Hold |
0
| – | -$4K | – | 7671 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 8253 |
|
|
2021
Q4 | – | Hold |
0
| – | -$12K | – | 9348 |
|
|
2021
Q3 | – | Hold |
0
| – | -$16K | – | 6640 |
|
|
2021
Q2 | – | Hold |
0
| – | -$45K | – | 6488 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 5657 |
|